AlphaCrest Capital Management’s Pediatrix Medical MD Stock Holding History

AlphaCrest Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,531	Closed	-$438K	–	684
2022 Q3	$438K	Buy	+26,531	New	+$534K	0.03%	1026
2022 Q2	–	Sell	-10,318	Closed	-$242K	–	1315
2022 Q1	$242K	Buy	+10,318	New	+$253K	0.01%	1164
2021 Q4	–	Sell	-31,130	Closed	-$885K	–	1405
2021 Q3	$885K	Buy	31,130 +20,761	+200%	+$633K	0.05%	665
2021 Q2	$313K	Buy	+10,369	New	+$306K	0.01%	1092
2021 Q1	–	Sell	-22,540	Closed	-$553K	–	1252
2020 Q4	$553K	Buy	+22,540	New	+$423K	0.05%	594
2020 Q2	–	Sell	-42,785	Closed	-$498K	–	1029
2020 Q1	$498K	Buy	42,785 +21,803	+104%	+$450K	0.06%	572
2019 Q4	$583K	Sell	20,982 -60,035	-74%	-$1.51M	0.05%	690
2019 Q3	$1.83M	Buy	81,017 +43,432	+116%	+$990K	0.11%	275
2019 Q2	$948K	Sell	37,585 -11,811	-24%	-$317K	0.08%	422
2019 Q1	$1.34M	Buy	49,396 +33,096	+203%	+$1.11M	0.2%	112
2018 Q4	$538K	Buy	+16,300	New	+$655K	0.16%	216

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

AlphaCrest Capital Management's MD Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Pediatrix Medical (MD) in Q4 2022, closing a stake of 26,531 shares — an estimated $438K sold.

AlphaCrest Capital Management first reported a position in MD in Q4 2018 and held it in 11 quarters. The position peaked at $1.83M in Q3 2019. 209 funds tracked by Wall St. Rank hold MD as of Q4 2022.

AlphaCrest Capital Management reported no remaining Pediatrix Medical position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 26,531 Pediatrix Medical shares in Q4 2022, an estimated $438K.
AlphaCrest Capital Management first reported a position in Pediatrix Medical in Q4 2018 and held it in 11 quarters.
AlphaCrest Capital Management's Pediatrix Medical position peaked at $1.83M in Q3 2019.
209 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.